-+ 0.00%
-+ 0.00%
-+ 0.00%

BRIEF-Ascletis Pharma Initiates U.S. Phase I Study For ASC36 Oral Tablets For Obesity

Reuters·09/08/2026 10:16:03

Please log in to view news